High-flow nasal oxygenation during gastrointestinal endoscopy. Systematic review and meta-analysis.
complications
digestive system endoscopy
gastrointestinal endoscopy
hypoxia
oxygen inhalation therapy
Journal
BJA open
ISSN: 2772-6096
Titre abrégé: BJA Open
Pays: England
ID NLM: 9918419157906676
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
12
01
2022
accepted:
14
09
2022
medline:
17
8
2023
pubmed:
17
8
2023
entrez:
17
8
2023
Statut:
epublish
Résumé
The use of high-flow nasal oxygen (HFNO) has the potential to improve patient safety by limiting hypoxaemia during gastrointestinal endoscopy. The degree of benefit is not adequately established. English language literature searches of PubMed, Scopus, Web of Science, and Cochrane Library electronic databases were performed to identify randomised controlled trials comparing HFNO and conventional oxygen therapy (COT) for patients undergoing gastrointestinal endoscopy under deep sedation. The primary endpoint was the incidence of hypoxic events observed during endoscopic procedures. The secondary endpoints were the incidence of recourse to rescue manoeuvres, procedure interruption, and adverse events. A meta-analysis and a A total of 2867 patients from six randomised controlled trials were considered. Desaturation was observed in 5.2% and 27.2% of patients receiving HFNO and COT, respectively. Desaturation <90% was observed in 1.8% and 12.6% of the patients receiving HFNO and COT, respectively. In the subgroup analysis, desaturation occurrence was lower during HFNO than during COT in non-obese patients (2.2% The evidence reviewed suggests that compared with COT, HFNO has fewer hypoxaemic events during gastrointestinal endoscopy, but this may not apply to all patients and clinical scenarios.
Sections du résumé
Background
UNASSIGNED
The use of high-flow nasal oxygen (HFNO) has the potential to improve patient safety by limiting hypoxaemia during gastrointestinal endoscopy. The degree of benefit is not adequately established.
Methods
UNASSIGNED
English language literature searches of PubMed, Scopus, Web of Science, and Cochrane Library electronic databases were performed to identify randomised controlled trials comparing HFNO and conventional oxygen therapy (COT) for patients undergoing gastrointestinal endoscopy under deep sedation. The primary endpoint was the incidence of hypoxic events observed during endoscopic procedures. The secondary endpoints were the incidence of recourse to rescue manoeuvres, procedure interruption, and adverse events. A meta-analysis and a
Results
UNASSIGNED
A total of 2867 patients from six randomised controlled trials were considered. Desaturation was observed in 5.2% and 27.2% of patients receiving HFNO and COT, respectively. Desaturation <90% was observed in 1.8% and 12.6% of the patients receiving HFNO and COT, respectively. In the subgroup analysis, desaturation occurrence was lower during HFNO than during COT in non-obese patients (2.2%
Conclusions
UNASSIGNED
The evidence reviewed suggests that compared with COT, HFNO has fewer hypoxaemic events during gastrointestinal endoscopy, but this may not apply to all patients and clinical scenarios.
Identifiants
pubmed: 37588780
doi: 10.1016/j.bjao.2022.100098
pii: S2772-6096(22)00097-1
pmc: PMC10430836
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100098Informations de copyright
© 2022 The Author(s).
Références
Br J Anaesth. 2018 Jan;120(1):18-27
pubmed: 29397127
Biomed Res Int. 2019 Jul 16;2019:4206795
pubmed: 31380421
Saudi J Gastroenterol. 2015 Nov-Dec;21(6):400-11
pubmed: 26655137
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Can J Anaesth. 2021 Apr;68(4):460-466
pubmed: 33403549
Laryngoscope. 2016 Jan;126(1):270-84
pubmed: 26198715
Korean J Anesthesiol. 2021 Aug;74(4):363-365
pubmed: 33333708
Clin Biomech (Bristol, Avon). 2019 May;65:73-80
pubmed: 30991233
Respir Med. 2017 Mar;124:15-20
pubmed: 28284316
J Appl Physiol (1985). 2010 Feb;108(2):430-5
pubmed: 19875707
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Gastrointest Endosc. 2019 Oct;90(4):591-601
pubmed: 31278907
Anesthesiology. 2009 Nov;111(5):979-87
pubmed: 19809292
Gastrointest Endosc. 2011 Aug;74(2):266-75
pubmed: 21704990
Br J Surg. 2020 Jan;107(2):e39-e55
pubmed: 31903602
Br J Anaesth. 2000 Jul;85(1):91-108
pubmed: 10927998
Respir Care. 2011 Aug;56(8):1151-5
pubmed: 21496369
Anesth Analg. 2021 Mar 1;132(3):743-751
pubmed: 32398433
Anesthesiology. 2003 Jan;98(1):28-33
pubmed: 12502975
Best Pract Res Clin Anaesthesiol. 2010 Jun;24(2):211-25
pubmed: 20608558
J Clin Anesth. 2019 May;54:19-24
pubmed: 30391445
Respir Care. 2016 Apr;61(4):529-41
pubmed: 27016353
Acta Anaesthesiol Scand. 1987 Jan;31(1):21-4
pubmed: 3825472
Respirology. 2012 Jan;17(1):43-9
pubmed: 22040049
Eur J Anaesthesiol. 2018 Jan;35(1):6-24
pubmed: 28877145
Clin Endosc. 2017 Mar;50(2):161-169
pubmed: 27126387
Br J Anaesth. 2021 Jul;127(1):133-142
pubmed: 33933271
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120